JCT  Vol.6 No.8 , August 2015
Is Peritoneal Cytology a Prognostic Factor in Endometrial Cancer?
Author(s) Jonathan Footefoote@musc.edu*, William T. Creasman
The International Federation of Gynecology and Obstetrics (FIGO) changed the surgical staging criteria for endometrial cancer in 2009, namely combining FIGO 1988 Stage IA and IB in FIGO 2009 Stage IA, eliminating cervical glandular involvement from Stage II, and removing peritoneal cytology as criteria from Stage IIIA (3). This review of the literature sheds light on the continued debate among authorities on the utility of peritoneal cytology in surgical staging of endometrial cancer. At the time FIGO removed peritoneal cytology from the staging criteria in 2009, there was little to no evidence to support its removal. In fact, FIGO continues to recommend obtaining peritoneal cytology, which is in contradiction to their staging criteria. While a few small studies support the idea that peritoneal cytology does not preclude a worse prognosis, a number of large scale studies with at least 300 patients demonstrate a clear association between survival and the presence of malignant peritoneal cytology (11 - 12, 15 - 19). In one of the largest studies, investigators reviewed 14,704 from the SEER’s database, demonstrating that malignant peritoneal cytology is associated with decreased survival across Stage I/II disease even when controlled for histology, grade, and other risk factors. Malignant peritoneal cytology should be considered when counseling patients on the risk of recurrence and overall survival of endometrial cancer. However, the role of adjuvant treatment in this setting remains unclear.

Cite this paper
Foote, J. and Creasman, W. (2015) Is Peritoneal Cytology a Prognostic Factor in Endometrial Cancer?. Journal of Cancer Therapy, 6, 665-669. doi: 10.4236/jct.2015.68073.
[1]   Creasman, W., Odicino, F., Maisonneuve, P., et al. (2006) Carcinoma of the Corpus Uteri. International Journal of Gynecology & Obstetrics, 95, S105-S143.

[2]   Creasman, W. (2009) Revised FIGO Staging for Carcinoma of the Endometrium. International Journal of Gynecology & Obstetrics, 105, 109.

[3]   Lewin, S. (2011) Revised FIGO Staging System for Endometrial Cancer. Clinical Obstetrics and Gynecology, 54, 215-218.

[4]   Creasman, W.T. and Rutledge, F.N. (1971) The Prognostic Value of Peritoneal Cytology in Gynecologic Malignant Disease. American Journal of Obstetrics & Gynecology, 110, 773.

[5]   Creasman, W.T., Disai, P.J., et al. (1981) Prognostic Significance of Peritoneal Cytology in Patients with Endometrial Cancer and Preliminary Data Concerning Therapy with Intraperitoneal Radiopharmaceuticals. American Journal of Obstetrics & Gynecology, 141, 921-929.

[6]   Yazigi, R. and Piver, M.S. (1982) Malignant Peritoneal Cytology as Prognostic Indicator in Stage I Endometrial Cancer. American Journal of Clinical Pathology, 77, 655.

[7]   Lurian, J.R., Rum Sey, N.K., Schink, J.C., et al. (1989) Prognostic Significance of Positive Peritoneal Cytology in Clinical Stage I Adenocarcinoma of the Endometrium. Obstetrics & Gynecology, 74, 175.

[8]   Grimshaw, R.N., Tupper, W.C., Fraser, R.C., et al. (1990) Prognostic Value of Peritoneal Cytology in Endometrial Carcinoma. Gynecologic Oncology, 36, 97.

[9]   Kasamatsu, T., Onda, T., et al. (2003) Prognostic Significance of Positive Peritoneal Cytology in Endometrial Carcinoma Confined to the Uterus. British Journal of Cancer, 88, 245-250.

[10]   Kyrgiou, M., et al. (2013) The Role of Cytology and Other Prognostic Factors in Endometrial Cancer. Journal of Obstetrics & Gynaecology, 33, 729-734.

[11]   Turner, D.A., Gershenson, D.M., Atkinson, N., et al. (1989) The Prognostic Significance of Peritoneal Cytology for Stage I Endometrial Cancer. Obstetrics & Gynecology, 74, 775.

[12]   Harouny, V.R., Sutton, E.P., Clark, S.A., et al. (1988) The Importance of Peritoneal Cytology in Endometrial Carcinoma. Obstetrics & Gynecology, 72, 394.

[13]   Morrow, C.P., et al. (1991) Relationship between Surgical-Pathological Risk Factors and Outcome in Clinical Stage I and II Carcinoma of the Endometrium: A Gynecological Oncology Group Study. Gynecologic Oncology, 40, 55-65.

[14]   Milosevic, M.F., Debmo, A.D. and Thomas, G.M. (1992) Clinical Significance of Malignant Peritoneal Cytology in Stage I Endometrial Carcinoma. International Journal of Gynecological Cancer, 2, 225.

[15]   Kashimura, M., Sugihara, K., et al. (1997) The Significance of Peritoneal Cytology in Uterine Cervix and Endometrial Cancer. Gynecologic Oncology, 67, 285-290.

[16]   Obermair, A., Geramou, M., et al. (2001) Peritoneal Cytology: Impact on Disease-Free Survival in Clinical Stage I Endometrioid Adenocarcinoma of the Uterus. Cancer Letters, 164, 105-110.

[17]   Saga, Y., Imai, M., et al. (2006) Is Peritoneal Cytology a Prognostic Factor of Endometrial Cancer Confined to the Uterus? Gynecologic Oncology, 103, 277.

[18]   Havrilesky, L.J. and Cragun, J.M. (2007) The Prognostic Significance of Positive Peritoneal Cytology and Adnexal/ Serosal Metastasis in Stage IIIA Endometrial Cancer. Gynecologic Oncology, 104, 401-405.

[19]   Garg, G., Gao, F., et al. (2013) Positive Peritoneal Cytology Is an Independent Risk-Factor in Early Stage Endometrial Cancer. Gynecologic Oncology, 128, 77-82.